DermTech, Inc. (DMTKQ) vs MDxHealth SA (MDXH)

DermTech, Inc. and MDxHealth SA are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $14.4M against $3.3M — 4.4× the size. MDxHealth SA grew revenue faster over the last twelve months: 21.5% against 9.71%. MDxHealth SA has the higher net margin (−32.5% vs −572.2%) and the higher return on invested capital (−23.8% vs −5,493.5%). Across the 16 metrics below, MDxHealth SA leads on 11 and DermTech, Inc. on 5.

Valuation

Metric DMTKQ MDXH Diagnostics & Research median
P/E n/m n/m 34.52
P/S n/m 0.07 4.24
P/B n/m n/m 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA 0.45 n/m 23.44
EV/Sales (2.49) 0.81 5.18
Earnings yield 0.00% (480.00%) (1.50%)
Free cash flow yield 0.00% (88.89%) 0.00%

Profitability

Metric DMTKQ MDXH Diagnostics & Research median
Gross margin 8.51% 63.23% 48.32%
Operating margin (588.62%) (18.04%) (5.68%)
Net margin (572.19%) (32.53%) (4.10%)
Free cash flow margin (460.10%) (5.24%) 0.00%
Return on equity (121.75%) 238.67% 0.00%
Return on assets (64.00%) (27.38%) (6.05%)
Return on invested capital (5,493.45%) (23.77%) 0.00%

Growth

Metric DMTKQ MDXH Diagnostics & Research median
Revenue growth (TTM) 9.71% 21.46% 8.99%
EPS growth (last fiscal year) 20.36% 42.24% 20.36%
Revenue growth, 5-year CAGR 44.33% 42.34% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMTKQ MDXH Diagnostics & Research median
Debt to equity 0.00 (3.42) 0.01
Current ratio 3.53 1.15 2.27
Net debt to EBITDA 0.57 (10.71) 0.68

Dividend

Metric DMTKQ MDXH Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric DMTKQ MDXH Diagnostics & Research median
Market cap 3.29m 14.40m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack